Clinical Trials on Breast Neoplasm in Germany

Total 6278 results

Pulsion Medical Systems SE

Unknown

ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes

Malignant Neoplasm of Breast

Germany
iOMEDICO AG
Novartis Pharmaceuticals; Arbeitsgemeinschaft fur Internistische Onkologie

Completed

Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab (IMPROVE)

Breast Cancer Recurrent | HER2/Neu-negative Carcinoma of Breast | Hormone Receptor Positive Malignant Neoplasm of Breast

Germany
Institut fuer Frauengesundheit
Eisai GmbH

Recruiting

Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)

Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, Breast

Germany
Palleos Healthcare GmbH
Pfizer; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP; AGO-TraFo; AGO-B; Deutsche...

Terminated

Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy (PRECYCLE)

Breast Neoplasm

Germany
Technical University of Munich

Unknown

Gated Radiotherapy in Left Sided Breast Cancer Patients (GATTUM)

Heart Diseases | Breast Neoplasm Female | Radiotherapy Side Effect

Germany
Universität Duisburg-Essen
Karl and Veronica Carstens Foundation

Completed

Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer (EOMI)

Breast Neoplasm

Germany
Novartis

Terminated

Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions

Breast Cancer With Bone Metastasis

Germany
Palleos Healthcare GmbH
Roche Pharma AG; University Hospital, Essen; University Hospital Erlangen; Phaon...

Active, not recruiting

Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy (neoMono)

Triple-negative Breast Cancer

Germany
German Breast Group
Novartis

Unknown

Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases (RADAR)

Breast Cancer

Germany
AstraZeneca

Terminated

Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment (CHIVE)

Breast Neoplasm

Korea, Republic of, Germany, Taiwan
West German Study Group
Celgene

Active, not recruiting

Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer (ADAPT)

Breast Cancer

Germany
Institut fuer Frauengesundheit
Merck Sharp & Dohme LLC

Active, not recruiting

Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO (COMPRENDO)

Breast Cancer | Malignant Neoplasm of Breast

Germany
University Hospital Tuebingen
University Hospital Freiburg; University Hospital Ulm

Recruiting

Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer

TNBC - Triple-Negative Breast Cancer

Germany
Institut fuer Frauengesundheit
Merck Sharp & Dohme LLC; Celgene Corporation

Completed

Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC (NIB)

Malignant Neoplasm of Breast

Germany
German Breast Group
Celgene Corporation; Amgen

Completed

Denosumab as an add-on Neoadjuvant Treatment (GeparX) (GeparX)

Inflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III

Germany
photonamic GmbH & Co. KG

Terminated

Fluorescence-guided Resection in Breast Cancer

Breast Tumour

Germany
pfm medical ag

Completed

Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket) (PRO-Pocket)

Breast Cancer | Breast Diseases | Breast Neoplasm | Breast Reconstruction After Mastectomy

Germany, Austria
University of Jena
University Hospital Erlangen; Labor Prof. Pachmann

Recruiting

Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age. (CETC)

Tumor Cell, Circulating

Germany
German Breast Group
Roche Pharma AG; Celgene Corporation

Completed

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) (GeparSepto)

Inflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IV

Germany
German Breast Group

Completed

Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE)

Primary Breast Cancer

Germany
German Breast Group

Terminated

Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA)

Metastatic Breast Cancer

Germany
Kliniken Essen-Mitte

Recruiting

Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant Therapy (Ultra3Detect)

Primary Breast Cancer

Germany
Prof. W. Janni
Roche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbH

Recruiting

Detect V / CHEVENDO (Chemo vs. Endo)

Metastatic Breast Cancer

Germany
University Hospital Tuebingen
Paul Ehrlich Institute, Langen, Germany

Completed

Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422) (KS2422-vacc)

Metastatic Breast Cancer

Germany
German Breast Group

Completed

Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer (AMICA)

Breast Cancer Metastatic

Germany
University of Jena

Completed

Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer Under Adjuvant Radiotherapy

Breast Cancer Female

Germany
iOMEDICO AG
Roche Pharma AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis...

Completed

Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer (CARIN)

Metastatic Breast Cancer

Germany
Novartis

Completed

Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy

Metastatic Breast Cancer

Germany
Ludwig-Maximilians - University of Munich
Pierre Fabre Laboratories

Completed

Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer

Carcinoma Breast Stage IV

Germany
Technical University of Munich
Eli Lilly and Company

Recruiting

Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients (Abemacare)

Breast Cancer/ Metastatic Breast Cancer

Germany
German Breast Group
AstraZeneca; Celgene

Completed

Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer (GeparNuevo)

Breast Cancer

Germany
Institut fuer Frauengesundheit
Novartis Pharmaceuticals; AGO Breast Study Group e.V.

Recruiting

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer (CLEAR-B)

Breast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer

Germany
Kliniken Essen-Mitte

Recruiting

TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes (SenTa2)

Breast Cancer | Node-positive Breast Cancer

Germany
RWTH Aachen University
Univ.-Prof. Dr. med. F. Kiessling

Unknown

KVUS at Neoadjuvant CTx of Breast Cancer

Early Primary Breast Cancer

Germany
German Breast Group
Boehringer Ingelheim

Completed

Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy (DAFNE)

Unilateral HER2 Positive Breast Cancer

Germany
German Breast Group
Pfizer

Completed

Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients (MALE)

Male Breast Cancer

Germany
AIO-Studien-gGmbH
Novartis Pharmaceuticals; iOMEDICO AG

Completed

Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer (VicTORia)

Her2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast Cancer

Germany
West German Study Group
Sanofi; Amgen

Completed

Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer (planB)

Primary Breast Cancer | Her2 Non-overexpressing

Germany
RWTH Aachen University

Recruiting

mULM to Support Breast Cancer Diagnosis and Therapy

Primary Breast Cancer

Germany
Prof. Wolfgang Janni
German Federal Ministry of Education and Research

Recruiting

Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer (SURVIVE)

Breast Cancer

Germany
European Breast Cancer Reseach Association of Surgical...
German Breast Group; North Eastern German Society of Gynaecological Oncology; AGO-... and other collaborators

Recruiting

AXillary Surgery After NeoAdjuvant Treatment (AXSANA)

Breast Cancer

Germany
Heinrich-Heine University, Duesseldorf

Not yet recruiting

NeoRad Breast Cancer Study

Breast Cancer

Germany
University Hospital Heidelberg

Recruiting

Intraoperative Electron Radiotherapy for Low-risk Early Breast Cancer (COSMOPOLITAN)

Breast Cancer

Germany
West German Study Group
Roche Pharma AG

Recruiting

A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol (ADAPT)

Breast Cancer

Germany
SamanTree Medical SA
St. Vincenz Krankenhaus GmbH, Paderborn

Completed

Assessment of Lumpectomy Margins With the Histolog Scanner in Comparison With Intraoperative Imaging Techniques (Polarhis)

Breast Cancer

Germany
Real Imaging Ltd.

Unknown

Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer

Breast Cancer

Germany
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer (INV181)

Breast Cancer

Germany
InSightec

Completed

Study of ExAblate Focused Ultrasound Ablation of Breast Cancer

Breast Cancer

Germany
North Eastern German Society of Gynaecological...

Completed

Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes

Breast Cancer

Germany
Novartis Pharmaceuticals
Roche - Prof. Dr. Jens Huober et al.

Terminated

Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer (eLEcTRA)

Metastatic Breast Cancer

Germany

Clinical Trials on Breast Neoplasm in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations